ArticleJournal of experimental & clinical cancer research : CR2019

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.

Elodie M Da Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.